Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

162
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
162

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell therapy in multiple sclerosis: An overview.

Revue neurologique·2026
Same author

Limb Girdle Muscular Dystrophy Associated With TRIM32 Variants: A National Cohort Study.

Muscle & nerve·2026
Same author

Target trial emulation for causal inference using observational data in neurology.

Revue neurologique·2026
Same author

Monitoring polycyclic aromatic hydrocarbons deposition in eastern Canada using moss biomonitoring: A large-scale study of spatial patterns and environmental influences.

The Science of the total environment·2026
Same author

Big multiple sclerosis data network: novel modelling approaches for real-world data analysis.

Journal of neurology·2025
Same author

Discussing with our patient a presymptomatic adult-onset neurological disease.

Revue neurologique·2025
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Related Experiment Video

Updated: Dec 13, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.0K

Pregnancy with multiple sclerosis.

S Vukusic1, L Michel2, S Leguy3

  • 1Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation et centre de recherche, ressources et compétences sur la sclérose en plaques, hospices civils de Lyon, 69677 Bron, France; Inserm 1028 et CNRS UMR 5292, observatoire français de la sclérose en plaques, centre de recherche en neurosciences de Lyon, 69003 Lyon, France; Université de Lyon, université Claude-Bernard Lyon 1, 69000 Lyon, France; Eugène Devic EDMUS Foundation against multiple sclerosis, state-approved foundation, 69677 Bron, France.

Revue Neurologique
|August 2, 2020
PubMed
Summary
This summary is machine-generated.

Pregnancy generally does not worsen multiple sclerosis (MS) and may improve symptoms. Managing disease-modifying treatments (DMTs) during pregnancy requires careful consideration due to limited safety data.

Keywords:
BreastfeedingDeliveryDisease modifying drugsMultiple sclerosisPregnancy

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

Related Experiment Videos

Last Updated: Dec 13, 2025

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.5K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.6K

Area of Science:

  • Neurology
  • Reproductive Medicine
  • Immunology

Background:

  • Multiple sclerosis (MS) is typically diagnosed in individuals of reproductive age (20-40 years).
  • Pregnancy's impact on MS course is complex, with individual factors influencing outcomes.
  • MS does not affect fertility or pregnancy progression; many women experience stable or improved symptoms during gestation.

Purpose of the Study:

  • To review the effects of pregnancy on multiple sclerosis.
  • To discuss the safety and management of disease-modifying treatments (DMTs) during pregnancy.
  • To address the clinical considerations for DMT use in pregnant individuals with MS.

Main Methods:

  • Literature review on pregnancy and MS.
  • Analysis of safety data for epidural and spinal analgesia in MS patients.
  • Evaluation of current recommendations and emerging data on DMT use in pregnancy.

Main Results:

  • Pregnancy is generally safe for women with MS and may lead to symptom improvement.
  • Epidural and spinal analgesia are considered safe for MS patients.
  • Limited data exists on the safety of most DMTs during pregnancy, especially newer agents.

Conclusions:

  • Discontinuing DMTs before conception is generally advised to minimize fetal risks.
  • For women with highly active MS, continuing DMTs until pregnancy confirmation or throughout gestation may prevent disease activity rebound and severe relapses.